fda glp-1 compounding enforcement news restricts non-approved compounded weight loss products Deceptive information and online sales

Track down patient assistance yourself

Patients starting GLP-1 therapy Patients adjusting doses Patients wanting to reduce side effects or progress Patients who love data or structure The Meds Supported medications Shotsy supports commonly prescribed GLP-1 treatments, including semaglutide and tirzepatide, in both injectable and oral forms, as well as brand-name and compounded options

During infection and antibiotic use, understanding your genetic predispositions can help your provider anticipate whether you'll experience amplified side effects

Tirzepatide is a novel dual GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonist recently approved for diabetes and weight loss

While lifestyle and genetics contribute, hormonal shifts are a major factor